Altering retroviral tropism using a random-display envelope library

Molecular Therapy

Volumn 5, Issue 3, 2002, Pages 329-335

  Bupp, Keith ^a   Roth, Monica J ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Feline leukemia virus; Gene targeting; Gene therapy; Peptide library; Retrovirus

Indexed keywords

CELL RECEPTOR; RETROVIRUS VECTOR; VIRUS ENVELOPE PROTEIN;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CELL SPECIFICITY; CONTROLLED STUDY; DOG; ENVELOPE GENE; FELINE LEUKEMIA VIRUS; GENE LIBRARY; GENETIC SCREENING; GENETIC SELECTION; GENETIC STABILITY; HOST RANGE; MAMMAL CELL; NONHUMAN; OSTEOSARCOMA; PROTEIN FUNCTION; PROTEIN ISOLATION; PROTEIN VARIANT; RETROVIRUS; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIROGENESIS;

ANIMALIA; CANIS FAMILIARIS; FELIDAE; FELINE LEUKEMIA VIRUS; MAMMALIA; SUBGROUP A; SUBGROUP C; UNIDENTIFIED RETROVIRUS;

EID: 0036194485     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1006/mthe.2002.0546     Document Type: Article

References (46)

1. Strategies and mechanisms for retrovirus retargeting
2. Targeting retrovirus entry
3. Targeting retroviral vectors to CD34-expressing cells: Binding to CD34 does not catalyze virus-cell fusion
4. Expression of chimeric envelope proteins in helper cell lines and integration into Moloney murine leukemia virus particles
5. Retroviral retargeting by envelopes expressing an N-terminal binding domain
6. Identification of the block in targeted retroviral-mediated gene transfer
7. Receptor choice determinants in the envelope glycoproteins of amphotropic, xenotropic, and polytropic murine leukemia viruses
8. Structure of a murine leukemia virus receptor-binding glycoprotein at 2.0 Å resolution
9. Identification of regions in the Moloney murine leukemia virus SU protein that tolerate the insertion of an integrin-binding peptide
10. Identification of envelope protein residues required for the expanded host range of 10A1 murine leukemia virus
11. Partial dissociation of subgroup C phenotype and in vivo behaviour in feline leukaemia viruses with chimeric envelope genes
12. Subgroup classification of feline leukemia and sarcoma viruses by viral interference and neutralization tests
13. Differential host range of viruses of feline leukemia-sarcoma complex
14. Feline leukemia virus subgroup B uses the same cell surface receptor as gibbon ape leukemia virus
15. Cloning of the cellular receptor for feline leukemia virus subgroup C (FeLV-C), a retrovirus that induces red cell aplasia
16. A putative cell surface receptor for anemia-inducing feline leukemia virus subgroup C is a member of a transporter superfamily
17. A transient three-plasmid expression system for the production of high-titer retroviral vectors
18. Strong sequence conservation among horizontally transmissible, minimally pathogenic feline leukemia viruses
19. High-titer packaging cells producing recombinant retroviruses resistant to human serum
20. Molecular analysis and pathogenesis of the feline aplastic anemia retrovirus, FeLV-C Sarma
21. The host range and interference properties of two closely related feline leukemia variants suggest that they use distinct receptors
22. Pathogenic and host range determinants of the feline aplastic anemia retrovirus
23. Isolation of a novel subgroup B feline leukemia virus from a cat infected with FeLV-A
24. Different murine cell lines manifest unique patterns of interference to superinfection by murine leukemia viruses
25. Interference grouping of murine leukemia viruses: A distinct receptor for the MCF-recombinant viruses in mouse cells
26. Lentiviral vectors pseudotyped with envelope glycoproteins derived from Gibbon ape leukemia virus and murine leukemia virus 10A1
27. A family of retroviruses that utilize related phosphate transporters for cell entry
28. Gene transfer into mammalian cells by a Rous sarcoma virus-based retroviral vector with the host range of the amphotropic murine leukemia virus
29. Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges
30. Construction and use of a safe and efficient amphotropic packaging cell line
31. Cloning of the cellular receptor for amphotropic murine retroviruses reveals homology to that for gibbon ape leukemia virus
32. A human amphotropic retrovirus receptor is a second member of the gibbon ape leukemia virus receptor family
33. Nucleotide sequences of a feline leukemia virus subgroup A envelope gene and long terminal repeat and evidence for the recombinational origin of subgroup B viruses
34. Molecular cloning of a feline leukemia virus that induces fatal immunodeficiency disease in cats
35. Gibbon ape leukemia virus and the amphotropic murine leukemia virus 4070A exhibit an unusual interference pattern on E36 chinese hamster cells
36. Major facilitator superfamily
37. Substitution of a single amino acid residue is sufficient to allow the human amphotropic murine leukemia virus receptor to also function as a gibbon ape leukemia virus receptor
38. Single amino acid insertion in loop 4 confers amphotropic murine leukemia virus receptor function upon murine Pit1
39. Comparative aspects of osteosarcoma: Dog versus man
40. Inhalation chemotherapy for macroscopic primary or metastatic lung tumors: Proof of principle using dogs with spontaneously occurring tumors as a model
41. Spontaneously occurring tumors of companion animals as models for human cancer
42. Targeting gene therapy to cancer: A review
43. Bystander killing of melanoma cells using the human tyrosinase promoter to express the Escherichia coli purine nucleoside phosphorylase gene
44. Osteocalcin-directed gene therapy for prostate-cancer bone metastasis
45. Characterization of chimeras between the ecotropic Moloney murine leukemia virus and the amphotropic 4070A envelope proteins
46. Three distinct envelope domains, variably present in subgroup B feline leukemia virus recombinants, mediate Pit1 and Pit2 receptor recognition